Search

Carmine Cuda

Examiner (ID: 8210)

Most Active Art Unit
3205
Art Unit(s)
3201, 3205, 2878
Total Applications
602
Issued Applications
542
Pending Applications
0
Abandoned Applications
60

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 356279 [patent_doc_number] => 07488715 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-10 [patent_title] => 'Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use' [patent_app_type] => utility [patent_app_number] => 11/213023 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14158 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/488/07488715.pdf [firstpage_image] =>[orig_patent_app_number] => 11213023 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/213023
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use Aug 25, 2005 Issued
Array ( [id] => 6978530 [patent_doc_number] => 20050288248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use' [patent_app_type] => utility [patent_app_number] => 11/212439 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14133 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20050288248.pdf [firstpage_image] =>[orig_patent_app_number] => 11212439 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/212439
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use Aug 25, 2005 Issued
Array ( [id] => 5894879 [patent_doc_number] => 20060003418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use' [patent_app_type] => utility [patent_app_number] => 11/213083 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14109 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003418.pdf [firstpage_image] =>[orig_patent_app_number] => 11213083 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/213083
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use Aug 25, 2005 Abandoned
Array ( [id] => 5894878 [patent_doc_number] => 20060003417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use' [patent_app_type] => utility [patent_app_number] => 11/213026 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14110 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003417.pdf [firstpage_image] =>[orig_patent_app_number] => 11213026 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/213026
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use Aug 25, 2005 Issued
Array ( [id] => 5894880 [patent_doc_number] => 20060003419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use' [patent_app_type] => utility [patent_app_number] => 11/213087 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14113 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003419.pdf [firstpage_image] =>[orig_patent_app_number] => 11213087 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/213087
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use Aug 25, 2005 Issued
Array ( [id] => 422031 [patent_doc_number] => 07273963 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-25 [patent_title] => 'Malarial animal model having a chimeric human liver' [patent_app_type] => utility [patent_app_number] => 11/207176 [patent_app_country] => US [patent_app_date] => 2005-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15083 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/273/07273963.pdf [firstpage_image] =>[orig_patent_app_number] => 11207176 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/207176
Malarial animal model having a chimeric human liver Aug 16, 2005 Issued
Array ( [id] => 5517083 [patent_doc_number] => 20090217390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Non-human animal sarcoma model' [patent_app_type] => utility [patent_app_number] => 11/919487 [patent_app_country] => US [patent_app_date] => 2005-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6580 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20090217390.pdf [firstpage_image] =>[orig_patent_app_number] => 11919487 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/919487
Non-human animal sarcoma model Apr 28, 2005 Abandoned
Array ( [id] => 6931730 [patent_doc_number] => 20050282765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Enzyme having S-adenosyl-L-homocysteine hydrolase (AHCY) type activity' [patent_app_type] => utility [patent_app_number] => 11/110748 [patent_app_country] => US [patent_app_date] => 2005-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5456 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282765.pdf [firstpage_image] =>[orig_patent_app_number] => 11110748 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/110748
Enzyme having S-adenosyl-L-homocysteine hydrolase (AHCY) type activity Apr 20, 2005 Abandoned
Array ( [id] => 7216476 [patent_doc_number] => 20050260165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'HS-40 enhancer-containing vector' [patent_app_type] => utility [patent_app_number] => 11/103355 [patent_app_country] => US [patent_app_date] => 2005-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3583 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260165.pdf [firstpage_image] =>[orig_patent_app_number] => 11103355 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/103355
HS-40 enhancer-containing vector Apr 10, 2005 Abandoned
Array ( [id] => 7004652 [patent_doc_number] => 20050169965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Compounds with improved cartilage-inducing and/or bone-inducing activity' [patent_app_type] => utility [patent_app_number] => 11/080494 [patent_app_country] => US [patent_app_date] => 2005-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5970 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20050169965.pdf [firstpage_image] =>[orig_patent_app_number] => 11080494 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/080494
Compounds with improved cartilage-inducing and/or bone-inducing activity Mar 15, 2005 Issued
Array ( [id] => 809886 [patent_doc_number] => 07416859 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-26 [patent_title] => 'Rhodococcus cloning and expression vectors' [patent_app_type] => utility [patent_app_number] => 11/069691 [patent_app_country] => US [patent_app_date] => 2005-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18167 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/416/07416859.pdf [firstpage_image] =>[orig_patent_app_number] => 11069691 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/069691
Rhodococcus cloning and expression vectors Feb 28, 2005 Issued
Array ( [id] => 7185205 [patent_doc_number] => 20050191744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Method for differentiating primate embryonic stem cell into vascular cell' [patent_app_type] => utility [patent_app_number] => 11/063584 [patent_app_country] => US [patent_app_date] => 2005-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9732 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20050191744.pdf [firstpage_image] =>[orig_patent_app_number] => 11063584 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/063584
Method for differentiating primate embryonic stem cell into vascular cell Feb 23, 2005 Issued
Array ( [id] => 5678345 [patent_doc_number] => 20060183701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Methods and compositions for determining non-specific cytotoxicity of a transfection agent' [patent_app_type] => utility [patent_app_number] => 11/059209 [patent_app_country] => US [patent_app_date] => 2005-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17808 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183701.pdf [firstpage_image] =>[orig_patent_app_number] => 11059209 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/059209
Methods and compositions for determining non-specific cytotoxicity of a transfection agent Feb 14, 2005 Abandoned
Array ( [id] => 5769433 [patent_doc_number] => 20050265978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Muscle-derived cells (MDCs) for treating muscle- or bone-related injury or dysfunction' [patent_app_type] => utility [patent_app_number] => 11/040900 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 33312 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20050265978.pdf [firstpage_image] =>[orig_patent_app_number] => 11040900 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/040900
Muscle-derived cells (MDCs) for treating muscle- or bone-related injury or dysfunction Jan 20, 2005 Issued
Array ( [id] => 123663 [patent_doc_number] => 07705197 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-27 [patent_title] => 'Embryo development and survival' [patent_app_type] => utility [patent_app_number] => 11/039662 [patent_app_country] => US [patent_app_date] => 2005-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6299 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/705/07705197.pdf [firstpage_image] =>[orig_patent_app_number] => 11039662 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/039662
Embryo development and survival Jan 18, 2005 Issued
Array ( [id] => 8386412 [patent_doc_number] => 08263821 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'Non-invasive real-time in vivo bioluminescence imaging of local CaÂ2+ dynamics in living organisms' [patent_app_type] => utility [patent_app_number] => 11/032236 [patent_app_country] => US [patent_app_date] => 2005-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 30 [patent_no_of_words] => 19013 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11032236 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/032236
Non-invasive real-time in vivo bioluminescence imaging of local CaÂ2+ dynamics in living organisms Jan 10, 2005 Issued
Array ( [id] => 7977235 [patent_doc_number] => 08071364 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => 'Gene therapy using transposon-based vectors' [patent_app_type] => utility [patent_app_number] => 10/583812 [patent_app_country] => US [patent_app_date] => 2004-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 33281 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071364.pdf [firstpage_image] =>[orig_patent_app_number] => 10583812 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/583812
Gene therapy using transposon-based vectors Dec 23, 2004 Issued
Array ( [id] => 6968874 [patent_doc_number] => 20050235367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Regulatory sequences capable of conferring expression of a heterologous DNA sequence in endothelial cells and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/015329 [patent_app_country] => US [patent_app_date] => 2004-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 18985 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20050235367.pdf [firstpage_image] =>[orig_patent_app_number] => 11015329 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/015329
Regulatory sequences capable of conferring expression of a heterologous DNA sequence in endothelial cells and uses thereof Dec 16, 2004 Abandoned
Array ( [id] => 7136619 [patent_doc_number] => 20050181395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Systems for tightly regulated gene expression' [patent_app_type] => utility [patent_app_number] => 11/010599 [patent_app_country] => US [patent_app_date] => 2004-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 8741 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20050181395.pdf [firstpage_image] =>[orig_patent_app_number] => 11010599 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/010599
Systems for tightly regulated gene expression Dec 12, 2004 Abandoned
Array ( [id] => 4684288 [patent_doc_number] => 20080250514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Expression Systems Using Mammalian Beta-Actin Promoter' [patent_app_type] => utility [patent_app_number] => 10/581183 [patent_app_country] => US [patent_app_date] => 2004-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12411 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20080250514.pdf [firstpage_image] =>[orig_patent_app_number] => 10581183 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/581183
Expression systems using mammalian beta-actin promoter Dec 2, 2004 Issued
Menu